Little is known about environmental causes of childhood cancer. This is probably due to the relative rarity of cancer in children. In the United States, cancer incidence in adults is over 20 times greater than cancer incidence in children. The situation is compounded by the fact that two groups of cancers, leukemias and brain and spinal tumors, account for half of all childhood cancers. The rarity of childhood cancer renders the conduct of most cohort studies infeasible. The majority of studies assessing potential environmental risk factors for childhood cancers have been case-control studies, which are highly efficient for studying rare diseases. Case-control studies of childhood cancers have been greatly facilitated by using cooperative clinical trial groups for case identification. The national studies that have emerged utilize random-digit telephone dialing and telephone interviewing as feasible and economic means of identifying and interviewing controls. Other approaches such as descriptive epidemiology, ecologic studies, and studies of cancer clusters have proven to be disappointing in elucidating environmental causes of childhood cancer. Descriptive and ecologic studies provide no information on specific exposures of study subjects; rather, they use population levels as surrogates for individual exposure. Studies of cancer clusters have also proven to be disappointing. Although there are numerous difficulties in conducting research on the causes of childhood cancer, these difficulties can be remedied by using carefully designed and conducted studies. It should be remembered that the epidemiologic approach is probably the most likely research venue for uncovering environmental causes of childhood cancer.
Introduction
Relatively little is known about the causes of cancer in childhood. In the 1950s, interest was focused on in utero diagnostic radiation exposure and risk of childhood leukemia (1) (2) (3) . Research interest next focused on the genetics of selected childhood cancers (4, 5) . The mechanism of transplacental carcinogenesis was demonstrated in the early 1970s (6) . In reviewing knowledge of the etiology of childhood cancer up until the 1980s, one is struck by the paucity of published etiologic studies relative to those of adult cancers. In large part, this is due to the relative rarity of cancer during childhood. Difficulty in the accrual of sufficiently large numbers of childhood cancer cases beyond leukemia (the type most frequent in childhood) has probably impeded research on the etiology of cancers in children. More recently, pediatric cooperative clinical trial groups have been identified and tapped as an important means for conducting etiologic research on cancers of childhood (7) . This has mitigated greatly the primary problem of having sufficient numbers of subjects to study childhood cancers properly. However, there remain significant problems in conducting research on environmental (and other) causes of cancer in children. This paper will review several methodologic issues that arise in conducting research on environmental causes of childhood cancer.
The Rarity Issue
The overall annual incidence of cancer in U.S. children 0 to 14 years of age at diagnosis is 143.9 per million for white males and 126.9 per million for white females. The comparable incidence rate for black males and females is 107.2 and 107.9 per million, respectively (8) . This is in contrast to 330.4 and 277.0 per 100,000 in white males and females, respectively, of all ages (9) . The comparable figures for black males and females of all ages are 351.3 and 227.1 per 100,000, respectively. Thus, adult incidence of cancer (all ages) in the United States is over 20 times greater than the cancer incidence in children 0 to 14 years of age at diagnosis. The rarity issue becomes even more salient when one looks at the incidence of childhood cancers beyond acute leukemias and brain cancers. The U.S. annual incidence of all leukemia is 47.8 per million in white males and 29. 5 per million in white females, and for brain and spinal tumors it is 26.4 and 23.3 in white male and female children, respectively (8) . Thus, leukemias account for 51.6 and 49.5% of all cancers in 0-to 14-year-old white males and females, respectively. Once we go beyond these two cancer groups, other groups are more truly rare diseases. For example, the incidence of rhabdomyosarcoma (RMS) in children is 5.0 and 4.4 per million in white males and females, and that of osteosarcoma is 2.3 and 2.7 per million in white males and females, respectively (8) . Accrual of subjects for studies of less common subsets of an already rare group of diseases becomes difficult even through the use of large cooperative treatment groups as sources of subjects. As will be discussed, the rarity issue has major impact on methodologic approaches to the study of childhood cancers. (6) . An astute obstetrician/gynecologist observed an unusual occurrence of these rare vaginal cancers in young women in his practice (6) . A case-control study was conducted to assess potential exposures that might be associated with risk of these rare cancers. This classic study found a striking association between the use of DES during pregnancy and subsequent development of vaginal adenocarcinoma in the young women exposed to DES in utero (6) . This observation provided considerable impetus to awareness of the mechanism of transplacental carcinogenesis. Unfortunately, observations such as these, which link extremely rare exposures with extremely rare malignancies, are themselves rare. For the vast majority of cancers, more difficult traditional epidemiologic methods must be used to uncover new potential risk factors.
Descriptiv Epidemiology
A fundamental approach frequently used to study the epidemiology of a disease is assessment of the way a disease occurs in a population. This is often termed descriptive epidemiology (11 The usual way the cluster is investigated is that the time frame selected for study is the period between the diagnosis of the first case and the last. The geographic frame for study is often the distance between the two cases living farthest apart. When the incidence of the disease in these time and geographic frames is computed, it is often alarmingly high. This approach is similar to the Texas sharpshooter. In a duster investigation, the time and space intervals become the target that is painted around the observed cluster. It is this post hoc definition of the study population and time frame that leads to spurious and often alarming reports of clusters greatly in excess of normal expectation.
However, not all studies of childhood cancer clustering are done in this post hoc fashion. Excellent statistical methods have been developed for assessing whether cases occur more closely together than would be expected by chance. These approaches usually are based on analysis of all cases of a disease occurring in large defined populations selected without prior observation of clustering (13, 14) .
Ecologic Studies
Another type of descriptive epidemiologic study is the so-called ecologic study. Eco 
The Cohort Study
In a cohort study, subjects are defined on the basis of their exposure status (15) . Usually a group of individuals who have been exposed to some environmental factor are followed over time to see whether or not they develop a disease (or diseases). A comparable group of unexposed individuals is followed similarly over time to see whether they develop the disease(s) of interest. This allows for comparison between the rates of disease occurrence in exposed and nonexposed persons. Often, general population rates of disease occurrence are used for comparison rather than control groups. Cohort studies involving childhood cancers are infrequently done. The childhood cancer cohort studies that have been done usually involve welldefined large groups of children that have had an uncommon exposure such as to ionizing radiation.
Adlvantags and Limitaions of Cohort Studies
A major advantage of the cohort study approach is that it works best for evaluating the health effects of rare exposures. Selecting and following a group of people who have had a very uncommon exposure is more likely to yield meaningful results than would a case-control study. It is most unlikely that in a case-control study of usual size, many subjects will have had a history of a rare exposure. Another advantage of cohort studies is that they allow for evaluating a variety of outcomes in relationship to a particular exposure or a category of exposures. Thus, in a cohort study of an occupational exposure, many outcomes can be evaluated in relation to the exposures being studied. This is in contrast to the case-control study approach in which only a single disease is studied, but multiple potential environmental exposures can be assessed.
A major limitation of cohort studies is that often it is difficult to determine the exposure status of people. It is not by accident that most cohort studies are of occupationally exposed people, as they can be identified relatively easily and the quality and quantity of their environmental exposures can often be determined. Another problem is posed by the inefficiency of cohort studies for assessing rare diseases or outcomes. To find enough cases of the rare disease, even if the risk is high following the exposure, extremely large cohorts of exposed individuals would have to be followed.
Perhaps the greatest problem posed by cohort studies is that they allow for the assessment of associations between the studied exposures and many different diseases. By looking at a large number of potentially associated diseases, some associations will be observed purely on the basis of chance. Thus, many associations reported in the literature might be due to chance rather than to a valid association, let alone a causal association.
The Case-Control Study Case-control studies are the type of epidemiologic study most frequently used by epidemiologists to assess potential causes of childhood cancer (16) . In the case-control study, subjects with a disease (or health condition) are the cases. Comparisons are then made with a group of subjects without the disease-the controls. Generally, cases and controls are matched on age, gender, and race. In studies of rare diseases such as childhood cancers, casecontrol studies are efficient, as subjects are selected because they have the disease of interest. In contrast to this, in a cohort study, very large numbers of exposed individuals would have to be studied to detect an elevated risk ofan extremely rare cancer.
Cases and controls are usually interviewed and data are collected on a variety of exposures they might have had prior to the onset of the cases' disease. Thus, case-control studies are retrospective. Case-control studies allow for study of many potential risk factors for disease but usually permit the study of only one disease at a time.
Advantages and Limitatons ofCase-Control Studies
Case-control studies are most advantageous for the study of uncommon diseases such as childhood cancers. Generally, case-control studies are relatively inexpensive because lengthy follow-up of subjects, often the case in cohort studies, is not necessary. However, most modern case-control studies of childhood cancers tend to be expensive and time-consuming because of difficulties in collecting sufficient numbers of cases for study and (17) . Because there was no state cancer registry at the time, cases were identified through North Carolina hospitals. Thirty-three RMS cases were collected over a 10-year period. Controls were identified via state birth certificates because it was felt that hospital controls might be a biased subset of North Carolina children. This study attempted to uncover some possible environmental risk factors (causes) for RMS. Because few hypotheses existed regarding the causes of this rare malignancy, information on a wide variety of potential causes was collected. We asked about smoking as well as several other exposures that also have adverse health effects. The most important finding emerging from this study was a strong association between fathers' cigarette smoking and RMS in their children. There was no association between mothers' smoking and RMS in their children. A biologically based hypothesis was developed to explain the finding and there seemed to be an important need to confirm or refute it (18) .
Because RMS is such a rare disease, we searched for ways to identify larger numbers of cases. We contacted the Intergroup Rhabdomyosarcoma Study (Omaha, NE), a cooperative clinical trials group, and they were extremely interested in doing a second case-control study. Although we finally had access to large numbers of cases, we could not come up with an economical and feasible means of identifying controls. Our first attempt was to have case parents select control families for us. This fared poorly in peer review because it was felt to be likely to yield a biased (nonrandom) group of controls. Our problem was finally solved by the use of random-digit telephone dialing to obtain controls. This technique uses a random number based on the case's telephone number. The random number is then called to see if a comparable child resides there and if the family is willing to participate.
We were then able to conduct a second, very large case-control study of over 300 RMS cases and a matched number of controls. It is likely that over 50% of all U.S. RMS cases were in our study. We found no association between fathers' (or mothers') cigarette smoking and RMS in their children. However, when we asked about smoking, we asked about several other exposures that also might have adverse health effects. These dummy variables were used to camouflage the questions about cigarette smoking. Much to our surprise, we found that parents' use of recreational drugs (marijuana and cocaine) was strongly associated with RMS risk in their children. Thus, one of our dummy variables was associated with risk of RMS (19) .
What Can Be Leaned from This Experience?
The most important lesson emerging from this experience was that cooperative clinical trial groups are excellent venues for the conduct of case-control studies of childhood cancer, particularly for the extremely rare cancers of childhood (7) . It also demonstrated that techniques for control selection such as random-digit dialing render the conduct of national case-control studies feasible. The reason for the conduct of studies that are national in scope and use subjects from cooperative clinical trial groups is that it allows for the accession of sufficiently large numbers of subjects with extremely rare cancers to allow for proper statistical analyses. It There has also been increasing interest in conducting ecologic studies of environmental factors in childhood cancer. Such studies might look at the relationship between residence near a dump site and the occurrence of childhood cancer in its immediate vicinity. These studies suffer from a lack of specific exposure data for the subjects involved. They are also likely to be confounded by socioeconomic and other factors. Thus, it is highly unlikely that useful information can be obtained on environmental causes from such studies.
Cohort studies of environmental causes of childhood cancer would be extremely difficult and unlikely to yield important new information other than in special situations. Usually, it is very difficult to identify a large enough cohort of children with a common set of exposures for study. It (21) . It would particularly facilitate ecologic and case-control studies. Development of such biomarkers should be a priority area for future research.
It is likely that genetic factors (i.e., hereditary susceptibility) play an important role in the etiology of many cancers of childhood. Children with a genetic predisposition for cancer may be particularly sensitive to environmental carcinogenic exposures. The Knudson two-mutation hypothesis of familial cancer occurrence is consistent with this notion (4). Thus, it should be fruitful in future epidemiologic research on childhood cancer to consider genetic-environmental interactions. The difficulty in conducting such research hinges on the rarity of most genetically related cancers of childhood. Again, the availability of a useful and economical laboratory measure of genetic susceptibility to childhood cancer would be a boon to epidemiologic research.
Another area for future research is the role of environmental factors in the causation of second malignancy in cancer patients. As treatment of childhood cancer becomes more successful, many patients will survive into adulthood. Some of these patients will develop second cancers, most of which are believed to be due to cancer therapy effects or to genetic predisposition. The question arises as to whether a cancer survivor's risk of second cancer might be increased further by environmental factors such as occupational exposures. This is a potentially fruitful area for new research.
In summary, there are numerous difficulties in conducting research aimed at elucidating the causes of childhood cancer. However, these difficulties are not insurmountable and can be remedied by the conduct of carefully designed and conducted studies. It must be remembered that the epidemiologic approach is probably the most likely research venue for uncovering the causes of childhood cancer.
